GlassScriptPhysician profile
Nilufer Yalcin
NPI 1457732125
$562.22
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2020: $20.45 · 2021: $11.05 · 2022: $57.95 · 2023: $209 · 2024: $33.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $242.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $154.33 | 2019-2023 | Soliris |
| Stryker Corporation | $145.92 | 2023 | Trevo |
| Emd Serono, INC. | $87.81 | 2019 | |
| Jazz Pharmaceuticals INC. | $43.87 | 2022-2023 | |
| Sk Life Science, INC. | $33.87 | 2024 | |
| Zoll Circulation INC | $31.31 | 2019 | |
| Csl Behring | $20.45 | 2020 | |
| Chiesi USA, INC. | $19.18 | 2022 | |
| Hyperfine Operations, INC. | $14.43 | 2023 | Swoop |
| Natus Medical Incorporated | $11.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nilufer Yalcin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.